Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
The Oncologist|April 17, 2020
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual DiseaseSahra Ali, Alexandre Moreau, Daniela Melchiorri, et al.American Journal of Nephrology|June 9, 2007
Anorexia in hemodialysis patients: the possible role of des-acyl ghrelinMaurizio Muscaritoli, Alessio Molfino, Maria Grazia Chiappini, et al.American Journal of Industrial Medicine|July 11, 2007
An old threat in a new setting: High prevalence of silicosis among jewelry workersNicola Murgia, Giacomo Muzi, Marco Dell'Omo, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 26, 2010
Interaction between Ephrins and mGlu5 metabotropic glutamate receptors in the induction of long-term synaptic depression in the hippocampusSonia Piccinin, Carlo Cinque, Laura Calò, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2002
Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neuronsAgata Copani, Daniela Melchiorri, Andrea Caricasole, et al.The Oncologist|June 15, 2014
The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for human useHector Boix-Perales, Jeanett Borregaard, Kristina Bech Jensen, et al.Psychoneuroendocrinology|July 27, 2007
Metabotropic glutamate receptors: beyond the regulation of synaptic transmissionFerdinando Nicoletti, Giuseppe Battaglia, Marianna Storto, et al.ESMO Open|September 27, 2019
European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapyKyriaki Tzogani, Beatriz Florez, Greg Markey, et al.ESMO Open|August 28, 2020
Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspectsLuca Moscetti, Paula Hennik, Bjorg Bolstad, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2005
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal deathIrene Cappuccio, Agata Calderone, Carla L Busceti, et al.Pageof 4